JENNIFER CREWS: Open Payments
NPI 1902173420 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,899 in 67 payments from 16 companies in 2025. Trend: 2023 $2,439 · 2024 $1,235 · 2025 $1,899
Food & beverage: $1,899
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $519 |
| Novartis Pharmaceuticals Corporation | 9 | $219 |
| Amgen Inc. | 9 | $205 |
| Galderma Laboratories, L.P. | 10 | $197 |
| UCB, Inc. | 4 | $173 |
| MERZ NORTH AMERICA, INC. | 1 | $149 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $149 |
| Regeneron Healthcare Solutions, Inc. | 5 | $89 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| GENZYME CORPORATION | 1 | $30 |
Products named: BOTOX, OTEZLA, NEMLUVIO, SKYRIZI, Bimzelx, Xeomin, Rhapsido, ILUMYA.
Industry payments across FL — which companies pay providers there.
